Source - SMW
Life sciences debt investor BioPharma Credit said it had agreed to be lead investor and collateral agent for a $315m loan.

The definitive, senior-secured loan was made to a commercial stage, private pharmaceutical company with pro-forma annual sales of around $250m.

BioPharma Credit said it would provide $194m of capital and co-investors would provide $121m.

Key terms included a five-year final maturity and a high-single-digit floating coupon, it said.


At 2:11pm: (LON:BPCR) Biopharma Credit Plc share price was +0.01p at 1.04p



Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.